Detalhe da pesquisa
1.
Antagonizing CD105 and androgen receptor to target stromal-epithelial interactions for clinical benefit.
Mol Ther
; 31(1): 78-89, 2023 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36045587
2.
Cancer epithelia-derived mitochondrial DNA is a targetable initiator of a paracrine signaling loop that confers taxane resistance.
Proc Natl Acad Sci U S A
; 117(15): 8515-8523, 2020 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32238563
3.
An Inhibitor of GSK3B and HDACs Kills Pancreatic Cancer Cells and Slows Pancreatic Tumor Growth and Metastasis in Mice.
Gastroenterology
; 155(6): 1985-1998.e5, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30144430
4.
AXIN2 expression predicts prostate cancer recurrence and regulates invasion and tumor growth.
Prostate
; 76(6): 597-608, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26771938
5.
Soluble CD105 is prognostic of disease recurrence in prostate cancer patients.
Endocr Relat Cancer
; 27(1): 1-9, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31648185
6.
Heterogeneous cancer-associated fibroblast population potentiates neuroendocrine differentiation and castrate resistance in a CD105-dependent manner.
Oncogene
; 38(5): 716-730, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30177832
7.
Single Particle Imaging of Polarized Hepatoma Organoids upon Hepatitis C Virus Infection Reveals an Ordered and Sequential Entry Process.
Cell Host Microbe
; 23(3): 382-394.e5, 2018 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29544098
8.
Antagonizing CD105 enhances radiation sensitivity in prostate cancer.
Oncogene
; 37(32): 4385-4397, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29717261
9.
Stromal epigenetic alterations drive metabolic and neuroendocrine prostate cancer reprogramming.
J Clin Invest
; 128(10): 4472-4484, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30047926
10.
Dual EGFR/HER2 inhibition sensitizes prostate cancer cells to androgen withdrawal by suppressing ErbB3.
Clin Cancer Res
; 17(19): 6218-28, 2011 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21844010
11.
Androgen Receptor regulation of Vitamin D receptor in response of castration-resistant prostate cancer cells to 1α-Hydroxyvitamin D5 - a calcitriol analog.
Genes Cancer
; 1(9): 927-940, 2010 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-21552398